📞 (586) 623-5616 ✉️ [email protected]
2026 hospice valuation multiples report with U.S. EBITDA benchmarks

Key Drivers of Hospice Valuation Multiples in 2026

A 2026 analysis of hospice and home health valuation multiples across the U.S. market. This report breaks down EBITDA multiples, explains how revenue ties into valuation, compares hospice vs home health trends, and outlines what buyers and sellers need to know in 2026.

Vallexa Advisors explains how falling interest rates increase healthcare M&A valuations and create exit opportunities for business owners

When the Window Opens: Why Falling Rates Create an Exit Moment for Healthcare Business Owners

Falling rates are lifting healthcare M&A valuations. Vallexa Advisors helps owners prepare early, create competitive tension, and time exits before the crowd. Capture the premium with disciplined process, sharper positioning, and buyer access.